Please assess the completion status of the following clinical trial:

Trial Title: Platelet Rich Plasma vs. Corticosteroid Injection in the Treatment of Partial Rotator Cuff Tears

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Shoulder pain for at least two weeks.~* Partial thickness articular sided rotator cuff tear diagnosed by MRI and musculoskeletal ultrasound.~Exclusion Criteria:~* Prior surgery to the injured shoulder~* Full thickness rotator cuff tear~* Pregnancy~* Cancer~* Current treatment with anticoagulation medication~* Steroid injection in the past 6 months in the injured shoulder~* Prior PRP treatment to the injured shoulder

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- platelet-rich plasma protein (PRP) (Type: EXPERIMENTAL): Subjects in this group will receive 2 injections with PRP. Each injection separated by two weeks.
- Corticosteroid (Type: ACTIVE_COMPARATOR): Subjects in this group will receive one injection with corticosteroids and then one injection with local anesthetic two weeks later.

Based on this trial design, predict the completion outcome and termination type (if applicable).